Literature DB >> 1008352

Antibodies against rifampin in patients with tuberculosis after discontinuation of daily treatment.

L Di Berardino, G Perna, L G Silvestri.   

Abstract

The presence of antibodies to rifampin was determined in sera of patients with tuberculosis on daily treatment one day after discontinuation of treatment, one week later, 3 weeks later, and 8 weeks later. The highest number of positive patients was found in the third week.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1008352     DOI: 10.1164/arrd.1976.114.6.1189

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  7 in total

1.  Do not miss rifampicin-induced thrombocytopenic purpura.

Authors:  Avinash Agrawal; Manish Gutch; Nirdesh Jain; Ambukeshwar Singh
Journal:  BMJ Case Rep       Date:  2012-02-25

2.  Intermittent treatment regimens in pulmonary tuberculosis.

Authors:  M Zierski
Journal:  Lung       Date:  1979       Impact factor: 2.584

3.  Acute subdural hemorrhage associated with rifampicin-induced thrombocytopenia.

Authors:  Sa-Yoon Kang; Jay Chol Choi; Ji-Hoon Kang; Jung Seok Lee
Journal:  Neurol Sci       Date:  2009-12-04       Impact factor: 3.307

4.  Rifampicin-induced thrombocytopenia.

Authors:  Ajay Kumar Verma; Arpita Singh; Amol Chandra; Santosh Kumar; Rajesh Kumar Gupta
Journal:  Indian J Pharmacol       Date:  2010-08       Impact factor: 1.200

5.  Rifampicin-induced thrombocytopenia.

Authors:  J W Hadfield
Journal:  Postgrad Med J       Date:  1980-01       Impact factor: 2.401

6.  Thrombocytopenia due to rifampicin.

Authors:  Ramakant Dixit; Jacob George; Arun Kumar Sharma
Journal:  Lung India       Date:  2012-01

7.  A case of thrombocytopenia caused by rifampicin and pyrazinamide.

Authors:  Rekha Bansal; Parveen K Sharma; Aradhna Sharma
Journal:  Indian J Pharmacol       Date:  2013 Jul-Aug       Impact factor: 1.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.